T. Rowe Price Group, Inc.

  • Market Cap: Mid Cap
  • Industry: Capital Markets
  • ISIN: US74144T1088
USD
105.79
3.32 (3.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About T. Rowe Price Group, Inc. stock-summary
stock-summary
T. Rowe Price Group, Inc.
Capital Markets
T. Rowe Price Group, Inc. is a financial services holding company. The Company provides global investment management services through its subsidiaries to investors across the world. The Company provides an array of Company sponsored the United States mutual funds, other sponsored pooled investment vehicles, sub advisory services, separate account management, recordkeeping, and related services to individuals, advisors, institutions, financial intermediaries and retirement plan sponsors. The Company distributes its products in countries located within three geographical regions: North America, Europe Middle East and Africa (EMEA), and Asia Pacific (APAC). It also offers specialized advisory services, including management of stable value investment contracts and a distribution management service for the disposition of equity securities its clients receive from third-party venture capital investment pools. As of December 31, 2016, it serviced clients in 45 countries across the world.
Company Coordinates stock-summary
Company Details
100 East Pratt Street, P.O. Box 89000 BALTIMORE MD : 21289-0320
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 136 Schemes (32.75%)

Foreign Institutions

Held by 342 Foreign Institutions (14.94%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. William Stromberg
Chairman of the Board, President, Chief Executive Officer
Mr. Mark Bartlett
Independent Director
Ms. Mary Bush
Independent Director
Ms. Dina Dublon
Independent Director
Dr. Freeman Hrabowski
Independent Director
Mr. Robert MacLellan
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1,723 Million
(Quarterly Results - Jun 2025)
Net Profit:
544 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

USD 23,767 Million (Mid Cap)

stock-summary
P/E

11.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

4.74%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

18.71%

stock-summary
Price to Book

2.25